2 November 2023
A&O advises Shionogi on its strategic joint venture with Apnimed for the development of therapies for obstructive sleep apnea and other sleep disorders
Advising firms
Deal team
10 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Matthew Appleton Lead | A&O Shearman | Partner | Healthcare Transactions | London |
| David Ingles Lead | A&O Shearman | Partner | Not stated | New York |
| Tokutaka Ito Lead | A&O Shearman | Partner | Not stated | Tokyo |
| Jim Ford Lead | A&O Shearman | Partner | Life Sciences | London |
| Soumya Sharma | A&O Shearman | Senior associate | Not stated | New York |
| Zara Sproul | A&O Shearman | Senior associate | Not stated | London |
| Megan McMellon | A&O Shearman | Associate | Not stated | London |
| Lucy Chen | A&O Shearman | Associate | Not stated | New York |
| Harsh Pais | A&O Shearman | Partner | Not stated | London |
| John Hibbard | A&O Shearman | Senior associate | Not stated | New York |
7 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Shionogi & Co., Ltd.Joint venture party
- Counterparties
- Apnimed, Inc. (Joint venture party)